ATRA vs ETN · rev $128.9M vs P/E 39, rev $27.45B
Atara Biotherapeutics Inc (ATRA) versus Eaton Corporation PLC (ETN) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported ETN revenue for 2025-12-31 was $27.45B. Net income was $4.09B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
ATRA currently screens at market cap $87.1M. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Not investment advice. Open the ATRA and ETN stock pages for the full models.
Not investment advice.